141 related articles for article (PubMed ID: 8564487)
1. Human saphenous vein organ culture: a useful model of intimal hyperplasia?
Porter KE; Varty K; Jones L; Bell PR; London NJ
Eur J Vasc Endovasc Surg; 1996 Jan; 11(1):48-58. PubMed ID: 8564487
[TBL] [Abstract][Full Text] [Related]
2. Human venous endothelium can promote intimal hyperplasia in a paracrine manner.
Allen KE; Varty K; Jones L; Sayers RD; Bell PR; London NJ
J Vasc Surg; 1994 Apr; 19(4):577-84. PubMed ID: 8164272
[TBL] [Abstract][Full Text] [Related]
3. Endothelin-B receptors mediate intimal hyperplasia in an organ culture of human saphenous vein.
Porter KE; Olojugba DH; Masood I; Pemberton M; Bell PR; London NJ
J Vasc Surg; 1998 Oct; 28(4):695-701. PubMed ID: 9786266
[TBL] [Abstract][Full Text] [Related]
4. Increased connexin43 expression in human saphenous veins in culture is associated with intimal hyperplasia.
Déglise S; Martin D; Probst H; Saucy F; Hayoz D; Waeber G; Nicod P; Ris HB; Corpataux JM; Haefliger JA
J Vasc Surg; 2005 Jun; 41(6):1043-52. PubMed ID: 15944608
[TBL] [Abstract][Full Text] [Related]
5. Insulin and local growth factor PDGF induce intimal hyperplasia in bypass graft culture models of saphenous vein and internal mammary artery.
Huang B; Dreyer T; Heidt M; Yu JC; Philipp M; Hehrlein FW; Katz N; Al-Fakhri N
Eur J Cardiothorac Surg; 2002 Jun; 21(6):1002-8. PubMed ID: 12048077
[TBL] [Abstract][Full Text] [Related]
6. Modulation of phosphatidylinositol 3-kinase signaling reduces intimal hyperplasia in aortocoronary saphenous vein grafts.
Hata JA; Petrofski JA; Schroder JN; Williams ML; Timberlake SH; Pippen A; Corwin MT; Solan AK; Jakoi A; Gehrig TR; Kontos CD; Milano CA
J Thorac Cardiovasc Surg; 2005 Jun; 129(6):1405-13. PubMed ID: 15942585
[TBL] [Abstract][Full Text] [Related]
7. Vein quality influences neointimal hyperplasia in an organ culture model of human saphenous vein.
Wilson YG; Davies AH; Southgate K; Currie IC; Sheffield E; Baird RN; Lamont PM; Angelini GD
Eur J Vasc Endovasc Surg; 1997 Jun; 13(6):557-62. PubMed ID: 9236708
[TBL] [Abstract][Full Text] [Related]
8. Production and inhibition of the gelatinolytic matrix metalloproteinases in a human model of vein graft stenosis.
Porter KE; Thompson MM; Loftus IM; McDermott E; Jones L; Crowther M; Bell PR; London NJ
Eur J Vasc Endovasc Surg; 1999 May; 17(5):404-12. PubMed ID: 10329524
[TBL] [Abstract][Full Text] [Related]
9. Influence of angioscopic vein graft preparation on development of neointimal hyperplasia in an organ culture model of human saphenous vein.
Wilson YG; Davies AH; Southgate K; Currie IC; Knight D; Patton D; Baird RN; Lamont PM; Angelini GD
J Endovasc Surg; 1996 Nov; 3(4):436-44. PubMed ID: 8959504
[TBL] [Abstract][Full Text] [Related]
10. The development of an in vitro flow model of human saphenous vein graft intimal hyperplasia.
Porter KE; Nydahl S; Dunlop P; Varty K; Thrush AJ; London NJ
Cardiovasc Res; 1996 Apr; 31(4):607-14. PubMed ID: 8689653
[TBL] [Abstract][Full Text] [Related]
11. Influence of Losartan, an angiotensin receptor antagonist, on neointimal proliferation in cultured human saphenous vein.
Varty K; Allen KE; Jones L; Sayers RD; Bell PR; London NJ
Br J Surg; 1994 Jun; 81(6):819-22. PubMed ID: 8044591
[TBL] [Abstract][Full Text] [Related]
12. Vein morphology and bypass graft stenosis.
Varty K; Porter K; Bell PR; London NJ
Br J Surg; 1996 Oct; 83(10):1375-9. PubMed ID: 8944432
[TBL] [Abstract][Full Text] [Related]
13. Comparison of response to injury in organ culture of human saphenous vein and internal mammary artery.
Holt CM; Francis SE; Newby AC; Rogers S; Gadsdon PA; Taylor T; Angelini GD
Ann Thorac Surg; 1993 Jun; 55(6):1522-8. PubMed ID: 8512406
[TBL] [Abstract][Full Text] [Related]
14. Endothelin-1 is a mediator of intimal hyperplasia in organ culture of human saphenous vein.
Masood I; Porter KE; London NJ
Br J Surg; 1997 Apr; 84(4):499-503. PubMed ID: 9112901
[TBL] [Abstract][Full Text] [Related]
15. Early growth response gene-1 decoy oligonucleotides inhibit vascular smooth muscle cell proliferation and neointimal hyperplasia of autogenous vein graft in rabbits.
Wang X; Mei Y; Ji Q; Feng J; Cai J; Xie S
Interact Cardiovasc Thorac Surg; 2015 Jul; 21(1):50-4. PubMed ID: 25820759
[TBL] [Abstract][Full Text] [Related]
16. Use of Brilliant Blue FCF during vein graft preparation inhibits intimal hyperplasia.
Osgood MJ; Sexton K; Voskresensky I; Hocking K; Song J; Komalavilas P; Brophy C; Cheung-Flynn J
J Vasc Surg; 2016 Aug; 64(2):471-478. PubMed ID: 27763268
[TBL] [Abstract][Full Text] [Related]
17. Association of smooth muscle cell phenotypic modulation with extracellular matrix alterations during neointima formation in rabbit vein grafts.
Zhang WD; Bai HZ; Sawa Y; Yamakawa T; Kadoba K; Taniguchi K; Masuda J; Ogata J; Shirakura R; Matsuda H
J Vasc Surg; 1999 Jul; 30(1):169-83. PubMed ID: 10394167
[TBL] [Abstract][Full Text] [Related]
18. Adenoviral delivery of a constitutively active retinoblastoma mutant inhibits neointima formation in a human explant model for vein graft disease.
Lamfers ML; Aalders MC; Grimbergen JM; de Vries MR; Kockx MM; van Hinsbergh VW; Quax PH
Vascul Pharmacol; 2002 Dec; 39(6):293-301. PubMed ID: 14567067
[TBL] [Abstract][Full Text] [Related]
19. The CCR5 chemokine receptor mediates vasoconstriction and stimulates intimal hyperplasia in human vessels in vitro.
Maguire JJ; Jones KL; Kuc RE; Clarke MC; Bennett MR; Davenport AP
Cardiovasc Res; 2014 Mar; 101(3):513-21. PubMed ID: 24323316
[TBL] [Abstract][Full Text] [Related]
20. Characterization of cellular density and determination of neointimal extracellular matrix constituents in human lower extremity vein graft stenoses.
Gentile AT; Mills JL; Westerband A; Gooden MA; Berman SS; Boswell CA; Williams SK
Cardiovasc Surg; 1999 Jun; 7(4):464-9. PubMed ID: 10430532
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
